Immunic(IMUX.US)

Last Updated 19:00:00 ET
longbridge loading

Immunic names Michael Bonney board chair, replacing interim chair Simona Skerjanec

PUBT·
US
IMUX
-2.74%
US
MRK
+0.57%
US
BIIB
-1.27%
PUBT·
US
IMUX
-2.74%
US
MRK
+0.57%
US
BIIB
-1.27%

Immunic Appoints Seasoned Biopharmaceutical Executive Michael W. Bonney as Chair of the Board of Directors | IMUX Stock News

StockTitan·
US
IMUX
-2.74%
StockTitan·
US
IMUX
-2.74%

Immunic (IMUX) Gets a Buy from LifeSci Capital

Tip Ranks·
US
IMUX
-2.74%
US
PBE
-0.24%
US
IXJ
+0.61%
Tip Ranks·
US
IMUX
-2.74%
US
PBE
-0.24%
US
IXJ
+0.61%

IMMUNIC, INC. 1Q 2026: Revenue $0 Net loss $32.6M — 10-Q Summary

TradingView·
US
IMUX
-2.74%
US
XLV
+0.80%
US
PBE
-0.24%
TradingView·
US
IMUX
-2.74%
US
XLV
+0.80%
US
PBE
-0.24%

Immunic, Inc. Reports First Quarter 2026 Financial Results and Provides Corporate Update | IMUX Stock News

StockTitan·
US
IMUX
-2.74%
US
IBB
-0.66%
US
ARKG
-1.14%
StockTitan·
US
IMUX
-2.74%
US
IBB
-0.66%
US
ARKG
-1.14%

06:30 ETImmunic to Participate in Investor and Medical Conferences in May

prnewswire·
US
IMUX
-2.74%
US
LABU
-5.13%
US
VHT
+0.68%
prnewswire·
US
IMUX
-2.74%
US
LABU
-5.13%
US
VHT
+0.68%
© 2026 Longbridge｜Disclaimer